Donald Trump’s pharmaceutical tariff to have ‘limited’ impact on biotech giant CSL: UBS
admin 7 hours agoLatest NewsComments Off on Donald Trump’s pharmaceutical tariff to have ‘limited’ impact on biotech giant CSL: UBS4 Views
Investment bank UBS expects Donald Trump’s tariff threat on pharmaceuticals to have ‘limited’ impact on biotech giant CSL, especially if plasma products are excluded.
